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Abstract  
 
Background: Schizophrenia first appears in adolescence, in boys at an earlier age than girls. The 
interpretation of this key epidemiological finding crucially depends on whether similar age-related sex 
differences exist in the expression of associated, subclinical psychosis-like experiences. Methods: 
Findings are based on a population sample of 2548 adolescents and young adults aged 17–28. Subjects 
were assessed with the core psychosis sections on delusions and hallucinations of the Munich- 
Composite International Diagnostic Interview. Results: The risk of subclinical psychotic experiences 
was significantly higher for males in the younger half of the cohort (17–21 years), but similar in the 
older half (22–28 years). Conclusions: These findings suggest that normal maturational changes in 
adolescence with differential age of onset in boys and girls cause the expression of psychosis, the 
extreme of which is schizophrenia.   
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The dramatic increase in the incidence of schizophrenia after puberty occurs at an earlier age 
in boys than in girls, causing the prevalence of the disorder to be higher in boys than in girls 
during adolescence (WHO, 1992; Konnecke et al., 2000). This epidemiological imbalance is 
thought to reflect sex differences in the timing of maturational events that facilitate the onset 
of psychotic disorder (Galdos et al., 1993; Kraepelin, 1919).  
 
One way to further elucidate the meaning of this key epidemiological finding is to examine 
whether a similar age-related sex difference exists in the expression of subtler, nonclinical but 
much more frequent psychotic experiences such as low-grade delusional ideas or auditory 
hallucinations that are continuous with the disorder but do not require treatment (Poulton et 
al., 2000).  
 
Several studies have shown that it is possible to measure, in the general population, the 
attenuated but structurally similar psychotic experiences that are encountered in clinical 
samples (van Os et al., 2001; Peters et al., 1999; Verdoux et al., 1998b). These subclinical 
manifestations of hallucinations and delusions have been shown to display similar 
associations with risk factors and demographic variables as have been reported for the clinical 
psychotic disorder (van Os et al., 2001; Verdoux et al., 1998a; Maric et al., 2003). Therefore, 
if the nonclinical psychotic experiences increase differentially with age in boys and girls in 
the same fashion as the clinical disorder schizophrenia (Fig. 1B), that is, if boys have a 
significantly earlier onset of subclinical symptoms than girls, a likely explanation would be 
that a normal, sex-related maturational event after puberty causes expression of psychosis 
along a continuum of severity. The implication of this would be that expression of lower 
grade psychotic experiences arises through the same mechanism as the disorder 
schizophrenia.  
 
However, if the sex differences in age of onset of schizophrenia are not reflected in similar 
sex differences in the age of onset of nonclinical psychotic experiences (Fig. 1A), it is 
unlikely that these normal maturational events themselves play a causal role in the expression 
of psychosis. Instead, they may merely facilitate the causal influence of a rare, early brain 
abnormality that is more common in males and remained ‘‘dormant’’ until after puberty as 
postulated in the neurodevelopmental hypothesis of schizophrenia (Murray and Lewis, 1988; 
Waddington et al., 1999; Weinberger, 1987).  
 
1. Subjects and methods  
 
1.1. Sample  
 
The Early Developmental Stages of Psychopathology (EDSP) study (Lieb et al., 2000) 
collected data on the prevalence, incidence, risk factors, comorbidity and course of mental 
disorders in a random representative population sample of adolescents and young adults (age 
range 14–24 years) in the Munich area (Germany). The overall design of the study is 
prospective, consisting of a baseline survey (n = 3021), two follow-up surveys and a family 
supplement. Fourteen- to fifteen-year-olds were sampled at twice the rate of persons 16–21 
years of age, and 22–24- year-olds were sampled at half this rate. A complete and detailed 
description of design, sample, instruments, procedures and statistical methods of the EDSP is 
given elsewhere (Wittchen et al., 1998).  
 
The baseline sample was drawn in 1994 from the government registries in Munich, Germany, 
of registrants expected to be 14–24 years of age at the time of the baseline interview in 1995. 
Details about the sampling and representativeness of the whole EDSP sample, along with its 
sociodemographic characteristics, have been previously presented (Lieb et al., 2000;Wittchen 
et al., 1998). A total of 3021 interviews were completed at baseline (T0; response rate, 71%). 
The first follow-up study (T1) was conducted only for respondents aged 14–17 years at 
baseline, whereas the second follow-up study was conducted for all respondents. The current 
results are based on the second follow-up. From the 3021 respondents of the baseline study, a 
total of 2548 interviews were completed at the second follow-up (T2), which occurred at an 
average of 42 months after baseline (response rate, 84%).  
 
1.2. Instruments  
 
Respondents were assessed with the computer-assisted version of the Munich-Composite 
International Diagnostic Interview (M-CIDI) (Wittchen, 1997), an updated version of the 
World Health Organization’s Composite International Diagnostic Interview version 1.2 
(WHO, 1990). The CIDI is designed for use by trained interviewers who are not clinicians 
and have high interrater reliability (Cottler et al., 1991; Wittchen et al., 1991) and high test–
retest reliability (Wittchen, 1994). Most interviews were carried out in the homes of the 
respondents. Trained and highly experienced clinical interviewers at the level of psychologist 
conducted all interviews. Interviewers were allowed to probe if necessary. At baseline, the 
lifetime version of the M-CIDI was used. At each of the follow-up assessments, we applied 
the MCIDI interval version, which refers to the period of assessment from the last interview 
until the present. Data on the M-CIDI G-section about psychosis were only present for the T2 
assessment, so these data are lifetime ratings.  
 
1.3. Psychosis ratings  
 
The ratings from the 15 M-CIDI core psychosis sections on delusions (11 items) and 
hallucinations (4 items) were used (items G3–G5, G7–G14, G17, G18, G20, G21). These 
concern classic psychotic symptoms involving, for example, persecution, thought interference 
and auditory hallucinations. All of these items can be rated in two ways: 1, no and 5, yes. The 
presence of positive psychotic experiences was broadly defined as any rating of 5 on any of 
the 15 M-CIDI core psychosis items.  
 
1.4. Statistical analysis  
 
All analyses were carried out using the software package STATA, version 7 (StataCorp, 
2001). Logistic regression analysis was performed in order to examine the association 
between any positive psychotic symptom on the one hand and age and sex on the other. The 
interaction between age and sex was assessed using the likelihood ratio test. A p-value < 0.05 
was considered statistically significant. In order to investigate whether any associations 
between sex and psychotic experiences were confounded by differences in substance abuse 
between boys and girls, the analyses were adjusted for substance abuse and separately for 
cannabis use as the most frequently used drug.  
 
2. Results  
 
The response rate at the second follow-up was 84.3% (n = 2548). The sample consisted of 
1299 males (50.9%) and the mean age was 21.7 years (S.D. = 3.4). The cumulative incidence 
of positive psychotic experiences was 17.5%, similar to previous population-based studies 
(van Os et al., 2001). Thus, 15.7% reported having had at least one delusional experience and 
4.6% reported having had at least one hallucinatory experience. In those who reported at least 
one psychotic experience, the mean age was lower in boys (21.3 years, S.D. = 3.3) than in 
girls (22.4 years, S.D. 3.5, t =-2.9, df = 440, P= 0.0042).  
 
Logistic regression indicated that there was no main effect of age (in years) or sex on the 
presence of at least one positive symptom (OR 1.00, 95% CI 0.97–1.03 and OR 0.92, 95% CI 
0.75–1.13, respectively). However, a significant interaction between age and sex was present 
(likelihood ratio test: χ2 = 6.7, p = 0.0097). Stratified analysis revealed that in the younger 
half of the cohort (split around the median age of 21 years), the risk of having a positive 
psychotic symptom was higher for males than for females (OR = 0.70, 95% CI 0.52–0.95), 
while no sex difference was found in the older cohort (OR = 1.18, 95% CI 0.89–1.58). The 
finding of differential sex ratios by age group remained even after controlling for substance 
abuse (interaction likelihood ratio test: χ2 = 7.7, p = 0.006) and separately for cannabis use 
(interaction likelihood ratio test: χ2 = 7.8, p = 0.005).  
 
3. Discussion  
 
Nonclinical experiences of psychosis showed differential sex distributions by age that 
resembled those reported for the clinical disorder schizophrenia. This suggests that sex 
differences in psychosis may reflect differential age-related variation of a continuous 
phenotype, rather than differential expression of a rare causal pathological risk factor.  
 
This contrasts with some previous hypotheses, in particular, that a rare early brain anomaly 
interacts with normal maturation to produce schizophrenia (Weinberger, 1987). The findings 
may be compatible with the hypothesis proposed by Feinberg (Keshavan et al., 1994) that 
variation in normal maturational processes may be related to the expression of psychosis. 
According to Feinberg, abnormalities in the elimination of synapses in the prefrontal cortex 
that takes place during adolescence may result in psychotic symptom formation. Adolescence 
is a critical period for the development of positive psychotic symptoms both in clinical and 
nonclinical samples (Verdoux et al., 1998b; Hafner et al., 1993).  
 
Age-related sex differences in these maturational processes, in particular, a significantly 
greater loss of cerebral grey matter in boys compared to girls (De Bellis et al., 2001), may 
represent the underlying mechanism of males showing an earlier age of onset of psychosis 
than females in a nonclinical sample, similar to results found in clinical samples.  
 
Raine (1992), Maric et al. (2003) and Tien (1991) reported that women have more positive 
‘‘paranormal’’ and psychosis-like experiences than men. This seems to contradict our 
findings. However, our study focussed on differential sex ratios by age group in adolescents 
and young adults. In contrast, the studies carried out by Raine (1992), Maric et al. (2002) and 
Tien (1991) focussed on main effects of sex on the prevalences of psychotic experiences 
across the entire adult age range. Therefore, we feel that our findings do not oppose these 
reports. In fact, each of these studies provides support for the hypothesis that associations 
with demographic risk factors in schizophrenia are mirrored in similar associations at lower 
levels of the continuum: In the current study, the sex ratio in the older adult part of our sample 
increased and rose well above unity, a directionally similar change as the ones reported by 
Raine (1992), Maric et al. (2002) and Tien (1991).  
 
A limitation of this work concerns the use of self-reported symptoms, although the use of 
face-to-face interviewing by psychologists with enough skills to ask follow-up questions and 
probe, if necessary, can be expected to yield a much better result than a self-report 
questionnaire or even a CIDI interview by trained lay interviewers. In the M-CIDI, the 
assessment of the symptoms does not include the degree of distress or disability associated 
with symptoms. Respondents who only have minor distress cannot be distinguished from 
respondents who have major distress. However, it has been demonstrated that psychotic or 
psychosis-like symptoms may occur in the population without any accompanying distress 
(van Os et al., 2001).  
 
Furthermore, previous work has shown that these self-reported experiences are valid as they 
are both aetiologically (van Os et al., 2001) and longitudinally (Poulton et al., 2000) on a 
continuum with clinical psychotic disorders.  
 
The use of cumulative incidence by age at interview may arguably represent another 
limitation. However, the age of the current population is so young that it is reasonable to 
assume that psychotic experiences were fairly recent in the majority of respondents. Even if 
the sample would include subjects who had their first psychotic experiences a few years ago, 
it is unlikely that this would have led to spurious results. In addition, a post hoc analysis in 
which the sample was restricted to those with psychotic experiences during the last year 
yielded essentially similar results (interaction likelihood ratio test: χ2 = 3.7, p = 0.05).  
 
In conclusion, two implications flow from these observations. First, the findings suggest that 
nonclinical and clinical psychotic experiences in adolescence are expressed along a 
continuum of severity. Second, brain maturational changes in adolescence with differential 
timing in males and females may cause expression of psychosis along the entire continuum.  
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